DOCSLIB.ORG

Pavlov, YI, Et Al. DNA Polymerases at the Eukaryotic Replication Fork

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pavlov, YI, Et Al. DNA Polymerases at the Eukaryotic Replication Fork cancers Correction Correction: Pavlov, Y.I., et al. DNA Polymerases at the Eukaryotic Replication Fork Thirty Years After: Connection to Cancer. Cancers 2020, 12, 3489 Youri I. Pavlov 1,2,* , Anna S. Zhuk 3 and Elena I. Stepchenkova 2,4 1 Eppley Institute for Research in Cancer and Allied Diseases and Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA 2 Department of Genetics and Biotechnology, Saint-Petersburg State University, 199034 Saint-Petersburg, Russia; [email protected] 3 International Laboratory of Computer Technologies, ITMO University, 197101 Saint-Petersburg, Russia; [email protected] 4 Laboratory of Mutagenesis and Genetic Toxicology, Vavilov Institute of General Genetics, Saint-Petersburg Branch, Russian Academy of Sciences, 199034 Saint-Petersburg, Russia * Correspondence: [email protected] The authors wish to make the following corrections to this paper [1] in the three last rows of Table1 occupying pages 1 and 2 where we detected errors in the names and molecular weights of subunits of human pol ζ. The original version of Table1 is: Table 1. Nomenclature of subunits of yeast and human B-family DNA polymerases *. Yeast, S. cerevisiae Human, H. sapiens Polymerase Subunit ** Protein, Also Protein, Also Citation: Pavlov, Y.I.; Zhuk, A.S.; Gene Gene (Size, kDa) Known As: (Size, kDa) Known As: Stepchenkova, E.I. Correction: Pavlov, primase Small (catalytic Pri1 PRIM1 PRI1 YIR008C PRIM1 p48, p49 Y.I., et al. DNA Polymerases at the -pol α primase) (48) (50) Large of Pri2 PRIM2 PRIM2A, Eukaryotic Replication Fork Thirty PRI2 YKL045W PRIM2 primase (62) (59) p58 Years After: Connection to Cancer. CDC17, POLA, Pol1 CRT5, POLA1 Cancers 2020, 12, 3489. Cancers 2021, Catalytic POL1 POLA1 NSX, (167) HPR3, (166) p180 13, 969. https://doi.org/10.3390/ YNL102W Pol12 POLA2 FLJ21662, cancers13050969 B-subunit POL12 YBL035C POLA2 (79) (66) p70 FILS, Received: 19 January 2021 POLE1, Pol2 DUN2, POLE Accepted: 21 January 2021 pol " Catalytic POL2 POLE IMADEI, (256) YNL262W (262) CRCS12, Published: 26 February 2021 p261 Dpb2 POLE2 DPE2, B-subunit DPB2 YPR175W POLE2 (78) (60) p59 Publisher’s Note: MDPI stays neutral CHRAC2, Dpb3 POLE3 Third DPB3 YBR278W POLE3 YBL1, with regard to jurisdictional claims in (23) (17) p17 published maps and institutional affil- Dpb4 POLE4 YHHQ1, Fourth DPB4 YDR121W POLE4 iations. (22) (12) p12 CDC2, CDC2, Pol3 HPR2, POLD1 MDPL, pol δ Catalytic POL3 POLD1 (125) TEX1, (124) CRCS10, YDL102W p125 HYS2, Pol31 HUS2, POLD2 Copyright: © 2021 by the authors. B-subunit POL31 POLD2 p50 (55) SDP5, (51) Licensee MDPI, Basel, Switzerland. YJR006W PPP1R128, This article is an open access article Pol32 REV5, POLD3 Third POL32 POLD3 KIAA0039, (40) YJR043C (51) distributed under the terms and p66 POLD4 POLDS, conditions of the Creative Commons Fourth - - POLD4 (12) p12 Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). Cancers 2021, 13, 969. https://doi.org/10.3390/cancers13050969 https://www.mdpi.com/journal/cancers Cancers 2021, 13, 969 2 of 3 Table 1. Cont. Yeast, S. cerevisiae Human, H. sapiens Polymerase Subunit ** Protein, Also Protein, Also Gene Gene (Size, kDa) Known As: (Size, kDa) Known As: REV3, Rev3 PSO1, REV3L HREV3, pol ζ Catalytic REV3 REV3L (173) YPL167C (353) POLZ p353 MAD2L2, p30, REV7, Rev7 HREV7 Second REV7 YIL139C hREV7 FANCV, (29) (24) MAD28, POLZ2, HYS2, Pol31 POLD3 B-subunit POL31 HUS2, POLD3 p50 (55) (50) SDP5 Pol32 POLD4 PPP1R128, Fourth POL32 REV5 POLD4 (40) (12) p66 *—mouse gene symbols are the same as humans but written using different capitalization: example for a gene is Pole, for a protein—POLe. **—the information on catalytic subunits is highlighted by bold font. The table should be replaced with the following Table1 with correct information in the three last rows and highlighted in bold the rows with information about catalytic subunits: Table 1. Nomenclature of subunits of yeast and human B-family DNA polymerases *. Yeast, S. cerevisiae Human, H. sapiens Polymerase Subunit ** Protein, Protein, Gene Also Known As: Gene Also Known As: (Size, kDa) (Size, kDa) Small (catalytic Pri1 PRIM1 PRI1 YIR008C PRIM1 p48, p49 primase) (48) (50) Pri2 PRIM2 PRIM2A, Large of primase PRI2 YKL045W PRIM2 primase (62) (59) p58 -pol α CDC17, Pol1 CRT5, POLA1 POLA, NSX, Catalytic POL1 POLA1 (167) HPR3, (166) p180 YNL102W Pol12 POLA2 FLJ21662, B-subunit POL12 YBL035C POLA2 (79) (66) p70 FILS, POLE1, Pol2 DUN2, POLE Catalytic POL2 POLE IMADEI, (256) YNL262W (262) CRCS12, p261 Dpb2 POLE2 DPE2, pol " B-subunit DPB2 YPR175W POLE2 (78) (60) p59 CHRAC2, Dpb3 POLE3 Third DPB3 YBR278W POLE3 YBL1, (23) (17) p17 Dpb4 POLE4 YHHQ1, Fourth DPB4 YDR121W POLE4 (22) (12) p12 CDC2, HPR2, CDC2, MDPL, Pol3 POLD1 Catalytic POL3 TEX1, POLD1 CRCS10, (125) (124) YDL102W p125 Pol31 HYS2, HUS2, SDP5, POLD2 B-subunit POL31 POLD2 p50 (55) YJR006W (51) pol δ PPP1R128, Pol32 REV5, POLD3 Third POL32 POLD3 KIAA0039, (40) YJR043C (51) p66 POLD4 POLDS, Fourth - - POLD4 (12) p12 Cancers 2021, 13, 969 3 of 3 Table 1. Cont. Yeast, S. cerevisiae Human, H. sapiens Polymerase Subunit ** Protein, Protein, Gene Also Known As: Gene Also Known As: (Size, kDa) (Size, kDa) REV3, Rev3 PSO1, REV3L Catalytic REV3 REV3L HREV3, POLZ (173) YPL167C (353) p353 hREV7, p30, Rev7 MAD2L2 Second REV7 YIL139C MAD2L2 FANCV, pol ζ (29) (24) MAD2B, POLZ2 Pol31 POLD2 B-subunit POL31 HYS2, HUS2, SDP5 POLD2 p50 (55) (51) Pol32 POLD3 PPP1R128, Fourth POL32 REV5 POLD3 (40) (51) p66 *—mouse gene symbols are the same as humans but written using different capitalization: example for a gene is Pole, for a protein—POLe. **—the information on catalytic subunits is highlighted by bold font. We stress that these errors were purely due to human error and oversight, all cor- rections done do not change the written portion of the table, or the final conclusion of this manuscript. The manuscript will be updated. The authors would like to apologize for any inconvenience caused. All changes have been reviewed and approved by the Academic Editors. Conflicts of Interest: The authors declare no conflict of interest. Reference 1. Pavlov, Y.I.; Zhuk, A.S.; Stepchenkova, E.I. DNA Polymerases at the Eukaryotic Replication Fork Thirty Years after: Connection to Cancer. Cancers 2020, 12, 3489. [CrossRef][PubMed].
Load more

Recommended publications
  • Telomeres.Pdf
    Telomeres Secondary article Elizabeth H Blackburn, University of California, San Francisco, California, USA Article Contents . Introduction Telomeres are specialized DNA–protein structures that occur at the ends of eukaryotic . The Replication Paradox chromosomes. A special ribonucleoprotein enzyme called telomerase is required for the . Structure of Telomeres synthesis and maintenance of telomeric DNA. Synthesis of Telomeric DNA by Telomerase . Functions of Telomeres Introduction . Telomere Homeostasis . Alternatives to Telomerase-generated Telomeric DNA Telomeres are the specialized chromosomal DNA–protein . Evolution of Telomeres and Telomerase structures that comprise the terminal regions of eukaryotic chromosomes. As discovered through studies of maize and somes. One critical part of this protective function is to fruitfly chromosomes in the 1930s, they are required to provide a means by which the linear chromosomal DNA protect and stabilize the genetic material carried by can be replicated completely, without the loss of terminal eukaryotic chromosomes. Telomeres are dynamic struc- DNA nucleotides from the 5’ end of each strand of this tures, with their terminal DNA being constantly built up DNA. This is necessary to prevent progressive loss of and degraded as dividing cells replicate their chromo- terminal DNA sequences in successive cycles of chromo- somes. One strand of the telomeric DNA is synthesized by somal replication. a specialized ribonucleoprotein reverse transcriptase called telomerase. Telomerase is required for both
    [Show full text]
  • Ailanthone Inhibits Non-Small Cell Lung Cancer Cell Growth Through Repressing DNA Replication Via Downregulating RPA1
    FULL PAPER British Journal of Cancer (2017) 117, 1621–1630 | doi: 10.1038/bjc.2017.319 Keywords: ailanthone; non-small cell lung cancer; DNA replication; RPA1; Chinese medicine Ailanthone inhibits non-small cell lung cancer cell growth through repressing DNA replication via downregulating RPA1 Zhongya Ni1, Chao Yao1, Xiaowen Zhu1, Chenyuan Gong1, Zihang Xu2, Lixin Wang3, Suyun Li4, Chunpu Zou2 and Shiguo Zhu*,1,3 1Laboratory of Integrative Medicine, School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, 1200 Cai Lun Rd, Shanghai 201203, PR China; 2Department of Internal Classic of Medicine, School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, 1200 Cai Lun Rd, Shanghai 201203, PR China; 3Department of Immunology and Pathogenic Biology, School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, 1200 Cai Lun Rd, Shanghai 201203, PR China and 4Department of Pathology, School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, 1200 Cai Lun Rd, Shanghai 201203, PR China Background: The identification of bioactive compounds from Chinese medicine plays a crucial role in the development of novel reagents against non-small cell lung cancer (NSCLC). Methods: High throughput screening assay and analyses of cell growth, cell cycle, apoptosis, cDNA microarray, BrdU incorporation and gene expression were performed. Results: Ailanthone (Aila) suppressed NSCLC cell growth and colony formation in vitro and inhibited NSCLC tumour growth in subcutaneously xenografted and orthotopic lung tumour models, leading to prolonged survival of tumour-bearing mice. Moreover, Aila induced cell cycle arrest in a dose-independent manner but did not induce apoptosis in all NSCLC cells.
    [Show full text]
  • Iron Depletion Reduces Abce1 Transcripts While Inducing The
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 22 October 2019 doi:10.20944/preprints201910.0252.v1 1 Research Article 2 Iron depletion Reduces Abce1 Transcripts While 3 Inducing the Mitophagy Factors Pink1 and Parkin 4 Jana Key 1,2, Nesli Ece Sen 1, Aleksandar Arsovic 1, Stella Krämer 1, Robert Hülse 1, Suzana 5 Gispert-Sanchez 1 and Georg Auburger 1,* 6 1 Experimental Neurology, Goethe University Medical School, 60590 Frankfurt am Main; 7 2 Faculty of Biosciences, Goethe-University Frankfurt am Main, Germany 8 * Correspondence: [email protected] 9 10 Abstract: Lifespan extension was recently achieved in Caenorhabditis elegans nematodes by 11 mitochondrial stress and mitophagy, triggered via iron depletion. Conversely in man, deficient 12 mitophagy due to Pink1/Parkin mutations triggers iron accumulation in patient brain and limits 13 survival. We now aimed to identify murine fibroblast factors, which adapt their mRNA expression 14 to acute iron manipulation, relate to mitochondrial dysfunction and may influence survival. After 15 iron depletion, expression of the plasma membrane receptor Tfrc with its activator Ireb2, the 16 mitochondrial membrane transporter Abcb10, the heme-release factor Pgrmc1, the heme- 17 degradation enzyme Hmox1, the heme-binding cholesterol metabolizer Cyp46a1, as well as the 18 mitophagy regulators Pink1 and Parkin showed a negative correlation to iron levels. After iron 19 overload, these factors did not change expression. Conversely, a positive correlation of mRNA levels 20 with both conditions of iron availability was observed for the endosomal factors Slc11a2 and Steap2, 21 as well as for the iron-sulfur-cluster (ISC)-containing factors Ppat, Bdh2 and Nthl1.
    [Show full text]
  • Supplementary Text and Figures.Pdf
    Supplemental Figure S2. PRIM1 immunoblots (20-75 kDa). (A) Corresponds to Figure 2D, with additional bands seen in P2 at 75 kDa and 25 kDa. (B) Independent experiment with cell lysates from C and P2 in which additional bands at 25 kDa not evident. (C) Corresponds to Figure 2D. No additional band visible at 25 kDa. (D) Validation of monoclonal antibody (8G10) with siRNA to PRIM1 in HeLa cells. siLUC, luciferase negative control. siPRIM1, siRNA targeting PRIM1 transcript. Vinculin used as a loading control. Supplemental Figure S3: Predicted destabilisation of PRIM1 by the C301R substitution. (A) Cysteine 301 lies in a buried hydrophobic region in PRIM1. DNA primase dimer crystal structure (PDB: 4BPU). PRIM1 residues shaded according to solvent accessibility. Cysteine 301, substituted to arginine in P5, lies in a buried hydrophobic region. (B) Cys301 is evolutionarily conserved in vertebrates. Neither arginine or other large or charged amino acids are observed at this position in other species. (C) The C301R substitution observed in P5 is predicted to lead to destabilisation of all available PRIM1 crystal structures. In contrast, substitution with leucine or threonine, as observed in some orthologous proteins, is not predicted to lead to destabilisation. Data points, predicted changes in free-energy (ΔΔG) from FoldX plotted for each of 14 available crystal structures. (D) Immunoblotting of RPE1 cells transfected with dual reporter constructs (as described in Figure 3B and Materials and Methods) confirms production of PRIM1-GFP and FLAG-SR at expected molecular weights and shows reduced protein levels for the C301R variant. n=2 experiments shown. C301R protein levels relative to WT after normalization to actin loading control indicated underneath the blot.
    [Show full text]
  • Replication Stress: an Achilles' Heel of Glioma Cancer Stem–Like Cells Meredith A
    Published OnlineFirst November 29, 2018; DOI: 10.1158/0008-5472.CAN-18-2439 Cancer Review Research Replication Stress: An Achilles' Heel of Glioma Cancer Stem–like Cells Meredith A. Morgan1, and Christine E. Canman2 Abstract Glioblastoma (GBM) is a highly aggressive form of cancer that Carruthers and colleagues investigated DNA replication stress as is resistant to standard therapy with concurrent radiation and an underlying mechanism responsible for upregulation of the temozolomide, two agents that work by inducing DNA damage. DDR and hence the radiation resistance of glioma stem–like An underlying causeof this resistance may be a subpopulation of cells. Furthermore, the authors explore the efficacy of combined cancer stem–like cells that display a heightened DNA damage ataxia telangiectasia and Rad3-related kinase and PARP inhibi- response (DDR). Although this DDR represents an attractive tors as a strategy to leverage these mechanisms and overcome therapeutic target for overcoming the resistance of GBMs to radiation resistance. Cancer Res; 78(24); 6713–6. Ó2018 AACR. radiotherapy, until now, the cause of this DDR upregulation has See related article by Carruthers and colleagues, Cancer Res; not been understood. In a previous issue of Cancer Research, 78(17); 5060–71. The cancer stem cell theory states that a small subpopulation of of replication factories compared with non-GSC populations tumor cells possess unique self-renewal properties that are capa- (6). These observations pointed to elevated levels of RS as ble of seeding new tumors and are a source of regrowth following causative of DDR activation in untreated GSCs, a hypothesis therapy (1). Glioma stem–like cells (GSC) are defined as CD133- supported by the high levels of RS in glioblastoma (GBM; positive cells that can initiate new tumors in mice (2).
    [Show full text]
  • POLE2 Knockdown Reduce Tumorigenesis in Esophageal Squamous Cells Yongjun Zhu, Gang Chen, Yang Song, Zhiming Chen* and Xiaofeng Chen*
    Zhu et al. Cancer Cell Int (2020) 20:388 https://doi.org/10.1186/s12935-020-01477-4 Cancer Cell International PRIMARY RESEARCH Open Access POLE2 knockdown reduce tumorigenesis in esophageal squamous cells Yongjun Zhu, Gang Chen, Yang Song, Zhiming Chen* and Xiaofeng Chen* Abstract Background: Esophageal squamous cell carcinoma (ESCC) is one of the most frequent malignant tumors originated from digestive system around the world and the treatment was limited by the unclear mechanism. DNA polymerase epsilon 2, accessory subunit (POLE2) is involved in DNA replication, repair, and cell cycle control, whose association with ESCC is still not clear. Methods: In this study, the expression level of POLE2 in ESCC tissues was detected by IHC. The POLE2 knockdown cell line was constructed, identifed by qPCR and western blot and used for detecting cellular functions and con- structing xenotransplantation mice model. MTT Assay, colony formation assay, fow cytometry, wound-healing assay and Transwell assay were used to detected cell proliferation, apoptosis and migration. Results: We frstly identifed that the expression of POLE2 was overexpressed in ESCC. Moreover, the high expres- sion of POLE2 can predict the tumor deterioration and poor prognosis of ESCC patients. Additionally, downregulation of POLE2 was involved in ESCC progression by promoting proliferation, migration, and inhibiting apoptosis in vitro. In vivo studies proved that POLE2 was positively correlated with ESCC tumor formation, which was consistent with the results in vitro. We also illuminated that POLE2 knockdown upregulated pro-apoptotic proteins (Bax, Caspase3, CD40L, FasL, IGFBP-5 and P21) and downregulated anti-apoptotic proteins (CLAP-2, IGF-I and sTNF-R2).
    [Show full text]
  • Congenital Microcephaly
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Sussex Research Online American Journal of Medical Genetics Part C (Seminars in Medical Genetics) ARTICLE Congenital Microcephaly DIANA ALCANTARA AND MARK O'DRISCOLL* The underlying etiologies of genetic congenital microcephaly are complex and multifactorial. Recently, with the exponential growth in the identification and characterization of novel genetic causes of congenital microcephaly, there has been a consolidation and emergence of certain themes concerning underlying pathomechanisms. These include abnormal mitotic microtubule spindle structure, numerical and structural abnormalities of the centrosome, altered cilia function, impaired DNA repair, DNA Damage Response signaling and DNA replication, along with attenuated cell cycle checkpoint proficiency. Many of these processes are highly interconnected. Interestingly, a defect in a gene whose encoded protein has a canonical function in one of these processes can often have multiple impacts at the cellular level involving several of these pathways. Here, we overview the key pathomechanistic themes underlying profound congenital microcephaly, and emphasize their interconnected nature. © 2014 Wiley Periodicals, Inc. KEY WORDS: cell division; mitosis; DNA replication; cilia How to cite this article: Alcantara D, O'Driscoll M. 2014. Congenital microcephaly. Am J Med Genet Part C Semin Med Genet 9999:1–16. INTRODUCTION mid‐gestation although glial cell division formation of the various cortical layers. and consequent brain volume enlarge- Furthermore, differentiating and devel- Congenital microcephaly, an occipital‐ ment does continue after birth [Spalding oping neurons must migrate to their frontal circumference of equal to or less et al., 2005]. Impaired neurogenesis is defined locations to construct the com- than 2–3 standard deviations below the therefore most obviously reflected clini- plex architecture and laminar layered age‐related population mean, denotes cally as congenital microcephaly.
    [Show full text]
  • Bioinformatics-Based Screening of Key Genes for Transformation of Liver
    Jiang et al. J Transl Med (2020) 18:40 https://doi.org/10.1186/s12967-020-02229-8 Journal of Translational Medicine RESEARCH Open Access Bioinformatics-based screening of key genes for transformation of liver cirrhosis to hepatocellular carcinoma Chen Hao Jiang1,2, Xin Yuan1,2, Jiang Fen Li1,2, Yu Fang Xie1,2, An Zhi Zhang1,2, Xue Li Wang1,2, Lan Yang1,2, Chun Xia Liu1,2, Wei Hua Liang1,2, Li Juan Pang1,2, Hong Zou1,2, Xiao Bin Cui1,2, Xi Hua Shen1,2, Yan Qi1,2, Jin Fang Jiang1,2, Wen Yi Gu4, Feng Li1,2,3 and Jian Ming Hu1,2* Abstract Background: Hepatocellular carcinoma (HCC) is the most common type of liver tumour, and is closely related to liver cirrhosis. Previous studies have focussed on the pathogenesis of liver cirrhosis developing into HCC, but the molecular mechanism remains unclear. The aims of the present study were to identify key genes related to the transformation of cirrhosis into HCC, and explore the associated molecular mechanisms. Methods: GSE89377, GSE17548, GSE63898 and GSE54236 mRNA microarray datasets from Gene Expression Omni- bus (GEO) were analysed to obtain diferentially expressed genes (DEGs) between HCC and liver cirrhosis tissues, and network analysis of protein–protein interactions (PPIs) was carried out. String and Cytoscape were used to analyse modules and identify hub genes, Kaplan–Meier Plotter and Oncomine databases were used to explore relationships between hub genes and disease occurrence, development and prognosis of HCC, and the molecular mechanism of the main hub gene was probed using Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway analysis.
    [Show full text]
  • Gene Expression Profiling Analysis Contributes to Understanding the Association Between Non-Syndromic Cleft Lip and Palate, and Cancer
    2110 MOLECULAR MEDICINE REPORTS 13: 2110-2116, 2016 Gene expression profiling analysis contributes to understanding the association between non-syndromic cleft lip and palate, and cancer HONGYI WANG, TAO QIU, JIE SHI, JIULONG LIANG, YANG WANG, LIANGLIANG QUAN, YU ZHANG, QIAN ZHANG and KAI TAO Department of Plastic Surgery, General Hospital of Shenyang Military Area Command, PLA, Shenyang, Liaoning 110016, P.R. China Received March 10, 2015; Accepted December 18, 2015 DOI: 10.3892/mmr.2016.4802 Abstract. The present study aimed to investigate the for NSCL/P were implicated predominantly in the TGF-β molecular mechanisms underlying non-syndromic cleft lip, signaling pathway, the cell cycle and in viral carcinogenesis. with or without cleft palate (NSCL/P), and the association The TP53, CDK1, SMAD3, PIK3R1 and CASP3 genes were between this disease and cancer. The GSE42589 data set found to be associated, not only with NSCL/P, but also with was downloaded from the Gene Expression Omnibus data- cancer. These results may contribute to a better understanding base, and contained seven dental pulp stem cell samples of the molecular mechanisms of NSCL/P. from children with NSCL/P in the exfoliation period, and six controls. Differentially expressed genes (DEGs) were Introduction screened using the RankProd method, and their potential functions were revealed by pathway enrichment analysis and Non-syndromic cleft lip, with or without cleft palate (NSCL/P) construction of a pathway interaction network. Subsequently, is one of the most common types of congenital defect and cancer genes were obtained from six cancer databases, and affects 3.4-22.9/10,000 individuals worldwide (1).
    [Show full text]
  • PRIM1 Polyclonal ANTIBODY Catalog Number:10773-1-AP 2 Publications
    For Research Use Only PRIM1 Polyclonal ANTIBODY www.ptglab.com Catalog Number:10773-1-AP 2 Publications Catalog Number: GenBank Accession Number: Purification Method: Basic Information 10773-1-AP BC005266 Antigen affinity purification Size: GeneID (NCBI): Recommended Dilutions: 150UL , Concentration: 133 μg/ml by 5557 WB 1:500-1:1000 Bradford method using BSA as the Full Name: IP 0.5-4.0 ug for IP and 1:200-1:1000 standard; primase, DNA, polypeptide 1 (49kDa) for WB Source: IHC 1:20-1:200 Calculated MW: IF 1:50-1:500 Rabbit 50 kDa Isotype: Observed MW: IgG 50 kDa Immunogen Catalog Number: AG1124 Applications Tested Applications: Positive Controls: IF, IHC, IP, WB, ELISA WB : K-562 cells, HeLa cells, Sp2/0 cells Cited Applications: IP : HeLa cells, IHC IHC : human lymphoma tissue, Species Specificity: human, mouse, rat IF : HeLa cells, Cited Species: mouse Note-IHC: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 DNA replication in human cells is initiated by a complex apparatus containing a DNA polymerase-alpha/primase Background Information complex. Primase synthesizes oligoribonucleotides that serve as primers for the initiation of DNA synthesis. It plays a role in both the initiation of DNA replication and the synthesis of Okazaki fragments for lagging strand synthesis. PRIM1 is a subnuit of this complex. Notable Publications Author Pubmed ID Journal Application Pierre Kunz 30986223 PLoS One IHC Liam C Hunt 31365869 Cell Rep Storage: Storage Store at -20°C. Stable for one year after shipment.
    [Show full text]
  • Polymerase Δ Deficiency Causes Syndromic Immunodeficiency with Replicative Stress
    Polymerase δ deficiency causes syndromic immunodeficiency with replicative stress Cecilia Domínguez Conde, … , Mirjam van der Burg, Kaan Boztug J Clin Invest. 2019. https://doi.org/10.1172/JCI128903. Research Article Genetics Immunology Graphical abstract Find the latest version: https://jci.me/128903/pdf The Journal of Clinical Investigation RESEARCH ARTICLE Polymerase δ deficiency causes syndromic immunodeficiency with replicative stress Cecilia Domínguez Conde,1,2 Özlem Yüce Petronczki,1,2,3 Safa Baris,4,5 Katharina L. Willmann,1,2 Enrico Girardi,2 Elisabeth Salzer,1,2,3,6 Stefan Weitzer,7 Rico Chandra Ardy,1,2,3 Ana Krolo,1,2,3 Hanna Ijspeert,8 Ayca Kiykim,4,5 Elif Karakoc-Aydiner,4,5 Elisabeth Förster-Waldl,9 Leo Kager,6 Winfried F. Pickl,10 Giulio Superti-Furga,2,11 Javier Martínez,7 Joanna I. Loizou,2 Ahmet Ozen,4,5 Mirjam van der Burg,8 and Kaan Boztug1,2,3,6 1Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, 2CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, and 3St. Anna Children’s Cancer Research Institute (CCRI), Vienna, Austria. 4Pediatric Allergy and Immunology, Marmara University, Faculty of Medicine, Istanbul, Turkey. 5Jeffrey Modell Diagnostic Center for Primary Immunodeficiency Diseases, Marmara University, Istanbul, Turkey. 6St. Anna Children’s Hospital, Department of Pediatrics and Adolescent Medicine, Vienna, Austria. 7Center for Medical Biochemistry, Medical University of Vienna, Vienna, Austria. 8Department of Pediatrics, Laboratory for Immunology, Leiden University Medical Centre, Leiden, Netherlands. 9Department of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, 10Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, and 11Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
    [Show full text]
  • DNA Ligase C and Primpolc Participate in Base Excision Repair in Mycobacteria
    DNA Ligase C and Prim-PolC participate in base excision repair in mycobacteria Article (Accepted Version) Plocinski, Przemyslaw, Brissett, Nigel C, Bianchi, Julie, Brzostek, Anna, Korycka-Machała, Małgorzata, Dziembowski, Andrzej, Dziadek, Jaroslaw and Doherty, Aidan J (2017) DNA Ligase C and Prim-PolC participate in base excision repair in mycobacteria. Nature Communications, 8 (1). a1251 1-12. ISSN 2041-1723 This version is available from Sussex Research Online: http://sro.sussex.ac.uk/id/eprint/70317/ This document is made available in accordance with publisher policies and may differ from the published version or from the version of record. If you wish to cite this item you are advised to consult the publisher’s version. Please see the URL above for details on accessing the published version. Copyright and reuse: Sussex Research Online is a digital repository of the research output of the University. Copyright and all moral rights to the version of the paper presented here belong to the individual author(s) and/or other copyright owners. To the extent reasonable and practicable, the material made available in SRO has been checked for eligibility before being made available. Copies of full text items generally can be reproduced, displayed or performed and given to third parties in any format or medium for personal research or study, educational, or not-for-profit purposes without prior permission or charge, provided that the authors, title and full bibliographic details are credited, a hyperlink and/or URL is given for the original metadata page and the content is not changed in any way. http://sro.sussex.ac.uk 1 2 DNA Ligase C and Prim-PolC participate 3 in base excision repair in mycobacteria 4 5 Przemysáaw PáociĔski1,2§, Nigel C.
    [Show full text]